Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash on Interstate 5 Near Cesar E. Chavez Parkway


Victim Hit by Several Vehicles in Fatal San Diego Accident 

San Diego, CA (March 15, 2020) – A pedestrian was killed after getting hit by multiple cars in San Diego. The fatal accident occurred on the evening of March 15 on Interstate 5.

The pedestrian was first hit in the southbound lanes of Interstate 5, near Cesar E. Chavez Parkway. The pedestrian was then run over by several other vehicles. They died at the accident scene. Several vehicles remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#San Diego

#92101


February 17, 2020

Alexis Castaneda Rodriguez Killed in Crash at San Pablo and Ashby Avenues

Man Hits Light Post in Fatal Berkeley Accident ...


March 4, 2020

1 Killed, 1 Injured in Crash on Interstate 15 at Via Rancho Parkway

Drugs, Alcohol Involved in Fatal Rancho Bernardo Accident...


December 26, 2019

3 Teens Killed, 2 Injured in Crash on Foothill Road

Car Hits Power Pole, Tree in Fatal Pleasanton Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.